Hedge Fund Database

CALIGAN PARTNERS

CALIGAN PARTNERS, LP Legal Name

Adviser information for CALIGAN PARTNERS last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Partnership
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 3
Investment Advisory/Research 3
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 11 $347.9M
Non-Discretionary 0 $0
Total 11 $347.9M

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 9 $328.4M
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other <5 $19.5M
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 18

Services

Advisory Services Portfolio management for individuals and/or small businessesPortfolio management for pooled investment vehiclesPORTFOLIO MANAGEMENT FOR OTHER INVESTMENT ADVISERS
Compensation % of AUMPerformance-based fees

Identifiers

SEC RIA File Number 801-113810
SEC ERA File Number 801-113810
SEC CIK Numbers 1727492
SEC CRD Numbers 289887
Legal Entity Identifier 549300FWK7CGQ83RTY05

Principal Office

515 MADISON AVENUE
8TH FLOOR
NEW YORK
NY
United States
Monday - Friday, 8:00 AM - 6:00 PM
Tel: 646-859-8204, Fax: None

Websites

www.caliganpartners.com/ www.linkedin.com/company/caligan-partners-lp/

Chief Compliance Officer

TIFFANY CROWLEY
CHIEF FINANCIAL OFFICER
515 MADISON AVE
8TH FLOOR
NEW YORK
NY
United States
Tel: 646-859-8207
(Full email address available in API data)

Regulatory Contact

DAVID JOHNSON
MANAGING PARTNER
515 MADISON AVE
8TH FLOOR
NEW YORK
NY
United States
Tel: 646-859-8204

Industry Affiliates

CALIGAN PARTNERS CV IV GP LLC Sponsor, GP, manager of pooled investment vehicles
CALIGAN PARTNERS CV V GP LLC Sponsor, GP, manager of pooled investment vehicles
CALIGAN PARTNERS CV VI GP LLC Sponsor, GP, manager of pooled investment vehicles
CALIGAN PARTNERS CV VII GP LLC Sponsor, GP, manager of pooled investment vehicles
CALIGAN PARTNERS FUND GP LLC Sponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
CALIGAN PARTNERS CV IV LP Hedge Fund $98.0M $0.1M 13
CALIGAN PARTNERS CV V LP Hedge Fund $9.6M $0.1M 9
CALIGAN PARTNERS CV VI LP Hedge Fund $36.0M $0.1M 25
CALIGAN PARTNERS CV VII LP Hedge Fund $0.0M $0.0M 0
CALIGAN PARTNERS MASTER FUND LP Hedge Fund $99.3M $5.0M 24

Control Persons

Name Type Entity Title Since Ownership
CALIGAN PARTNERS GP LLC Domestic Entity – GENERAL PARTNER 08/2017 < 5%
JOHNSON, DAVID, EDWARD Individual – PARTNER / LIMITED PARTNER 08/2017 > 75%
JOHNSON INVESTMENT TRUST Domestic Entity – LIMITED PARTNER 08/2017 10-25%
JOHNSON, DAVID, EDWARD Individual CALIGAN PARTNERS GP LLC MEMBER 08/2017 > 75%
JOHNSON, SARAH, BATES Individual JOHNSON INVESTMENT TRUST TRUSTEE 08/2017
CROWLEY, TIFFANY Individual – CHIEF FINANCIAL OFFICER/CHIEF COMPLIANCE OFFICER 11/2021 < 5%
LAMAN, ROBERT, THOMAS Individual – CHIEF OPERATING OFFICER 11/2021 < 5%

No. Employees, Historic

105020192020202120222023202420252 on 10/10/20192 on 1/21/20203 on 3/26/20203 on 4/1/20202 on 3/25/20212 on 3/31/20212 on 4/30/20213 on 11/16/20213 on 3/30/20223 on 6/3/20223 on 3/30/20233 on 5/4/20233 on 3/28/2024

RAUM, Historic

400M200M0201920202021202220232024202530647804 on 10/10/201930647804 on 1/21/202044045112 on 3/26/202044045112 on 4/1/202067389921 on 3/25/202167389921 on 3/31/202167389921 on 4/30/202167389921 on 11/16/2021121231644 on 3/30/2022121231644 on 6/3/2022139778522 on 3/30/2023139778522 on 5/4/2023347914853 on 3/28/2024

No. Clients, Historic

2010020192020202120222023202420253 on 10/10/20193 on 1/21/20201 on 3/26/20201 on 4/1/20208 on 3/25/20218 on 3/31/20218 on 4/30/20218 on 11/16/20219 on 3/30/20229 on 6/3/20229 on 3/30/20239 on 5/4/202311 on 3/28/2024

Holdings

From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
AGIOS PHARMACEUTICALS INC COM 22M 515K –
ALIMERA SCIENCES INC COM NEW 94M 17M –
ANIKA THERAPEUTICS INC COM 36M 1M –
BIOCRYST PHARMACEUTICALS INC COM 28M 5M –
ENANTA PHARMACEUTICALS INC COM 14M 1M –
EVOLUS INC COM 24M 2M –
EXELIXIS INC COM 34M 2M –
I MAB SPONSORED ADS 6M 3M –
LIQUIDIA CORPORATION COM NEW 124M 10M –
MINERALYS THERAPEUTICS INC COM 9M 746K –
OUTLOOK THERAPEUTICS INC COM 4M 500K –
VERONA PHARMA PLC SPONSORED ADS 27M 2M –
Y-MABS THERAPEUTICS INC COM 7M 582K –